Medistim ASA (OSL:MEDI)

Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 4.30 billion. The enterprise value is 4.12 billion.

Market Cap	4.30B
Enterprise Value	4.12B

Important Dates

The next confirmed earnings date is Wednesday, August 19, 2026.

Earnings Date	Aug 19, 2026
Ex-Dividend Date	May 7, 2026

Share Statistics

Medistim ASA has 18.29 million shares outstanding.

Current Share Class	18.29M
Shares Outstanding	18.29M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	10.18%
Owned by Institutions (%)	77.58%
Float	11.31M

Valuation Ratios

The trailing PE ratio is 27.54 and the forward PE ratio is 25.28.

PE Ratio	27.54
Forward PE	25.28
PS Ratio	5.97
PB Ratio	8.48
P/TBV Ratio	10.61
P/FCF Ratio	25.29
P/OCF Ratio	24.50
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.71, with an EV/FCF ratio of 24.26.

EV / Earnings	26.42
EV / Sales	5.73
EV / EBITDA	19.71
EV / EBIT	21.24
EV / FCF	24.26

Financial Position

The company has a current ratio of 3.80, with a Debt / Equity ratio of 0.07.

Current Ratio	3.80
Quick Ratio	2.56
Debt / Equity	0.07
Debt / EBITDA	0.17
Debt / FCF	0.20
Interest Coverage	43.04

Financial Efficiency

Return on equity (ROE) is 32.08% and return on invested capital (ROIC) is 47.16%.

Return on Equity (ROE)	32.08%
Return on Assets (ROA)	18.68%
Return on Invested Capital (ROIC)	47.16%
Return on Capital Employed (ROCE)	35.15%
Weighted Average Cost of Capital (WACC)	9.82%
Revenue Per Employee	4.53M
Profits Per Employee	981,635
Employee Count	159
Asset Turnover	1.11
Inventory Turnover	0.85

Taxes

In the past 12 months, Medistim ASA has paid 45.58 million in taxes.

Income Tax	45.58M
Effective Tax Rate	22.60%

Stock Price Statistics

The stock price has increased by +10.48% in the last 52 weeks. The beta is 1.01, so Medistim ASA's price volatility has been similar to the market average.

Beta (5Y)	1.01
52-Week Price Change	+10.48%
50-Day Moving Average	221.22
200-Day Moving Average	236.04
Relative Strength Index (RSI)	59.11
Average Volume (20 Days)	28,837

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 719.89 million and earned 156.08 million in profits.

Revenue	719.89M
Gross Profit	581.05M
Operating Income	194.12M
Pretax Income	201.66M
Net Income	156.08M
EBITDA	200.36M
EBIT	194.12M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 209.79 million in cash and 34.60 million in debt, with a net cash position of 175.19 million or 9.58 per share.

Cash & Cash Equivalents	209.79M
Total Debt	34.60M
Net Cash	175.19M
Net Cash Per Share	9.58
Equity (Book Value)	506.74M
Book Value Per Share	n/a
Working Capital	362.44M

Cash Flow

In the last 12 months, operating cash flow was 175.49 million and capital expenditures -5.49 million, giving a free cash flow of 169.99 million.

Operating Cash Flow	175.49M
Capital Expenditures	-5.49M
Depreciation & Amortization	6.25M
Net Borrowing	-10.06M
Free Cash Flow	169.99M
FCF Per Share	9.29

Margins

Gross margin is 80.71%, with operating and profit margins of 26.96% and 21.68%.

Gross Margin	80.71%
Operating Margin	26.96%
Pretax Margin	28.01%
Profit Margin	21.68%
EBITDA Margin	27.83%
EBIT Margin	26.96%
FCF Margin	23.61%

Dividends & Yields

This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 3.40%.

Dividend Per Share	8.00
Dividend Yield	3.40%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	1
Payout Ratio	70.13%
Buyback Yield	n/a
Shareholder Yield	3.39%
Earnings Yield	3.63%
FCF Yield	3.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6